(Q30416631)

English

Introduction of silent mutations into the NP gene of influenza A viruses as a possible strategy for the creation of a live attenuated vaccine

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Introduction of silent mutations into the NP gene of influenza A viruses as a possible strategy for the creation of a live attenuated vaccine (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

attenuated vaccine

1 reference

based on heuristic

inferred from title

object named as

Stephan Ludwig

4

0 references

Christoph Scholtissek

3

object named as

Christoph Scholtissek

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

author name string

Darisuren Anhlan

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Eike-Roman Hrincius

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

7 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

4480-4489

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Molecular studies of temperature-sensitive replication of the cold-adapted B/Ann Arbor/1/66, the master donor virus for live attenuated influenza FluMist vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Live attenuated influenza virus vaccines by computer-aided rational design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Disruption of the viral polymerase complex assembly as a novel approach to attenuate influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

An M2 cytoplasmic tail mutant as a live attenuated influenza vaccine against pandemic (H1N1) 2009 influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Architecture of ribonucleoprotein complexes in influenza A virus particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Selective incorporation of influenza virus RNA segments into virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Characterisation of influenza A viruses with mutations in segment 5 packaging signals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

An influenza virus containing nine different RNA segments.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Evidence for segment-nonspecific packaging of the influenza a virus genome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

A nine-segment influenza a virus carrying subtype H1 and H3 hemagglutinins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

cis-Acting packaging signals in the influenza virus PB1, PB2, and PA genomic RNA segments

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Rewiring the RNAs of influenza virus to prevent reassortment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Importance of both the coding and the segment-specific noncoding regions of the influenza A virus NS segment for its efficient incorporation into virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Specific residues of the influenza A virus hemagglutinin viral RNA are important for efficient packaging into budding virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Taming influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Molecular evolution of influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

The influenza virus resource at the National Center for Biotechnology Information

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

A DNA transfection system for generation of influenza A virus from eight plasmids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Synergistic adaptive mutations in the hemagglutinin and polymerase acidic protein lead to increased virulence of pandemic 2009 H1N1 influenza A virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Novel vaccines against influenza viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Analysis of influenza A virus nucleoproteins for the assessment of molecular genetic mechanisms leading to new phylogenetic virus lineages.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Mutational analysis of cis-acting RNA signals in segment 7 of influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Evidence for specific packaging of the influenza A virus genome from conditionally defective virus particles lacking a polymerase gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Codon conservation in the influenza A virus genome defines RNA packaging signals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

Evolution of the nucleoprotein gene of influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.070

7 January 2021

based on heuristic

inferred from DOI database lookup

A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/OXFORDJOURNALS.AJE.A118408

Identifiers

10.1016/J.VACCINE.2012.04.070

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30416631&oldid=1775255138"